Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
combination
Biotech
Enanta pulls plug on NASH, seeks to offload assets for combos
After getting a look at interim phase 2b data, the biotech has decided to stop the monotherapy trial and seek to outlicense its candidates.
Nick Paul Taylor
Oct 4, 2021 8:40am
Otsuka and Proteus sign 5-year, $88M digital pill partnership
Oct 11, 2018 10:33am
FDA could end 'confusing and inefficient' drug-device process
May 16, 2018 8:45am
Pfizer culls 5 experimental cancer trials in Q1 clear out
May 1, 2018 9:26am
Merck inks $394M takeover of oncolytic virus play Viralytics
Feb 21, 2018 5:39am
Otsuka, Proteus refile for FDA approval of digital medicine
May 24, 2017 9:50am
